SCHEMBL26556300

SCHEMBL26556300

CCN(CC)c1ccc(C(=O)c2ccccc2C(=O)OCCOCCNC(=O)CCN2C(=O)C=CC2=O)c(O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ L3MBTL1 Q9Y468 3/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ ALDH1A1 P00352 4/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ POLB P06746 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ LMNA P02545 7/20 0.34
▸ TP53 P04637 4/20 0.34
▸ HTT P42858 1/20 0.34
▸ MAOB P27338 1/20 0.33
▸ MAPT P10636 6/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ NFKB1 P19838 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ NFKB2 Q00653 1/20 0.32
▸ RELA Q04206 1/20 0.32
▸ HTR3A P46098 1/20 0.32
▸ THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23571279 0.95 SMN1; SMN2 (0.50) SMN1; SMN2L3MBTL1MEN1KMT2AALDH1A1
SCHEMBL30025662 0.95 SMN1; SMN2 (0.50) SMN1; SMN2L3MBTL1MEN1KMT2AALDH1A1
SCHEMBL13808697 0.85 L3MBTL1 (0.58) SMN1; SMN2L3MBTL1MEN1KMT2AALDH1A1
SCHEMBL13301475 0.82 L3MBTL1 (0.67) SMN1; SMN2L3MBTL1MEN1KMT2AALDH1A1
SCHEMBL23571278 0.82 L3MBTL1 (0.54) SMN1; SMN2L3MBTL1MEN1KMT2AALDH1A1
SCHEMBL669854 0.82 L3MBTL1 (0.54) SMN1; SMN2L3MBTL1MEN1KMT2AALDH1A1
SCHEMBL13301476 0.79 L3MBTL1 (0.72) SMN1; SMN2L3MBTL1MEN1KMT2AALDH1A1
SCHEMBL13301485 0.75 L3MBTL1 (0.69) SMN1; SMN2L3MBTL1MEN1KMT2AALDH1A1
SCHEMBL13301464 0.75 L3MBTL1 (0.69) SMN1; SMN2L3MBTL1MEN1KMT2AALDH1A1
SCHEMBL23571306 0.75 L3MBTL1 (0.54) SMN1; SMN2L3MBTL1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230323028-A1 ADHESIVE PHOTOPROTECTIVE COMPOUNDS AND USES THEREOF SKINOSIVE (FR) 2023-10-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230323028-A1 ADHESIVE PHOTOPROTECTIVE COMPOUNDS AND USES THEREOF ICAM1, CDH1, VCAM1 SMN1; SMN2 3957/4885L3MBTL1 2580/4885MEN1 1875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback